Company Overview

Company name: Steep Hill Labs
Description: Provider of medical cannabis testing and analytics service designed to measure the potency and safety of all cannabinoid infused products and medicines. The company’s services use premium instruments and qualified methodologies to quantify up to 20 cannabinoids, as many as 42 terpenes, microbiological/pesticide contaminants and residual solvents, enabling cannabis cultivators to improve their product.
Year founded: 2008
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Website: www.steephill.com
Employees: 30
City: Berkeley
State: California
Country: United States
Region: Americas

Financial Highlights

Start up capital raised (USD Million): 9.35
Business status: Generating Revenue
Ownership: Privately Held (backing)
Exchange:
Ticker:
Revenue (USD Million): 0.00
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period: FY 2015
Financing Status: The company raised an undisclosed amount of venture funding from Merida Capital Partners on August 27, 2018. Previously, the company raised $2.5 million of Series 3 venture funding from Gotham Green Partners and Slifka Asset Management on November 13, 2017. Merida Capital Partners also participated in the round.
Number of active investors:
Profile last updated: 23-Nov-2018
Last known valuation: 12.00
Last known valuation date: 25-Nov-2015